In today’s uncertain times, many of the leading pharmaceutical companies are in search for a cure for COVID-19. Some of our largest customers such as Regeneron, Johnson & Johnson, Pfizer, NIH, and Merck have been conducting extensive research to combat this virus. Regeneron is in phase 2/3 for clinical trials of REN-COV2 which is an Anti-viral, antibody cocktail. NIH, Johnson & Johnson, and Merck have made multiple scientific efforts to battle COVID-19. Pfizer has announced detecting early positive data from ongoing phase 1/2 study of mRNA based vaccine candidate against SARS-CoV-2.
Rees Scientific is proud to partner with these renowned institutions and honored to be a part of the process in developing crucial vaccines and medications. We share the same common goal of patient safety with these industry leaders. Our system continuously monitors their valuable research, samples and assets for fluctuation in temperature, humidity, differential pressure and more. If there is any deviation within the given values, they will receive alarm notification via phone, e-mail or text. They receive information-rich event history reports that are easy to understand which help meet compliance for the toughest regulatory requirements. The Rees monitoring system is used in 8 out of the top 10 pharmaceutical companies, trusted by the US military and government agencies such as CDC and FDA. Rees Scientific will continue to support the development of a solution for this evolving global crisis in any means possible.
